622830-64-2

Basic information

• Product Name: O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide
• Synonyms: O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide
• CAS NO: 622830-64-2
• Molecular Weight: 841.785
• Mol File: 622830-64-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide(CAS DataBase Reference)
• NIST Chemistry Reference: O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide(622830-64-2)
• EPA Substance Registry System: O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide(622830-64-2)

Safety Data

• Hazardous Substances Data: 622830-64-2(Hazardous Substances Data)

Upstream product

• 70831-94-6 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-D-glucopyranosyl bromide 
• 10022-13-6 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranose 
• 622830-63-1 O-(2,3,4-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl)-(1->4)-6-O-(tert-butyldiphenylsilyl)-3-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranosyl azide 

Downstream Products

• 622830-71-1 C₇₁H₈₇N₇O₂₂ 
• 622830-69-7 C₆₉H₈₄N₆O₂₁ 
• 622830-76-6 C₅₈H₇₉N₇O₂₁ 
• 622830-67-5 N^α-(9-fluorenylmethoxycarbonyl)-N^γ-[O-(2-deoxy-2-acetamido-β-D-glucopyranosyl)-(1->4)-[O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1->6)]-3-O-benzyl-2-deoxy-2-acetamido-β-D-glucopyranosyl]-L-asparagine tert-butyl ester 
• 1054749-26-6 C₄₁H₅₆F₅N₇O₂₁ 
• 622830-70-0 C₅₄H₇₄N₆O₁₉ 
• 622830-66-4 O-(2-deoxy-2-acetamido-β-D-glucopyranosyl)-(1->4)-[O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1->6)]-3-O-benzyl-2-deoxy-2-acetamido-β-D-glucopyranosyl azide 

Relevant articles and documents

Synthesis and CD structural studies of CD52 peptides and glycopeptides

The syntheses of five natural and N-terminal acetylated peptides and glycopeptides of the CD52 antigen are described. Solid phase peptide synthesis was employed in the construction of the target compounds from Fmoc-protected commercial amino acids and syn